miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells

The incidence of liver cancer ranks seventh globally, with nearly half of all cases occurring in East Asia, but currently, there are very few drugs to treat it. Our previous studies demonstrated that the signal integration protein Gab2 is a potential drug target for the prevention and therapy of liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lantang, Liu, Ruimin, Zhou, Peiyi, Tian, Yingpu, Lu, Zhongxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690539/
https://www.ncbi.nlm.nih.gov/pubmed/36421826
http://dx.doi.org/10.3390/genes13112152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690539/
https://www.ncbi.nlm.nih.gov/pubmed/36421826
http://dx.doi.org/10.3390/genes13112152

Ejemplares similares